Background: Vulvovaginal candidiasis (VVC) is one of the most common fungal infections encountered during pregnancy. Hormonal alterations, immunological modulation, and changes in vaginal microenvironment predispose pregnant women to Candida colonization and symptomatic infection. The increasing emergence of non-albicans Candida species and antifungal resistance has posed diagnostic and therapeutic challenges, particularly in pregnancy where treatment options are limited. Aim and Objectives: To